Terms of Use

The information on this site is provided for reference only. It is not medical advice, does not constitute a diagnosis, and is not a substitute for consultation with a qualified health professional. Always consult your physician or another qualified clinician before making any decision about treatment or medication, and never disregard professional medical advice because of something you have read here.

By using this site you agree to these terms. If you do not agree, please do not use the site.

This site is an informational reference that summarizes publicly available data about drugs, diseases, and companies. It is not a medical service, is not a healthcare provider, and is not involved in patient care or treatment decisions.

Content is derived from public sources — ClinicalTrials.gov study records and FDA product labeling. This site summarizes and structures that data but does not guarantee that it is complete, current, or free of transcription errors. Always verify important information against the original source before relying on it.

Pages link to third-party websites — ClinicalTrials.gov, FDA pages, journals, and other publishers — for verification and further reading. We do not control the content of those sites and are not responsible for it.

Please do not use automated tools to scrape or bulk-download the site in a way that degrades service for other visitors, and do not misrepresent the data shown here as your own proprietary research.

Clinical trial records and FDA labeling information remain subject to the terms of their sources. The original presentation, curation, and composition on this site are our own.

The site is provided "as is" without warranties of any kind, express or implied. To the extent permitted by law, this site and its operators shall not be liable for any damages arising from its use, including any decisions made on the basis of its content.

These terms may be updated as the site evolves; revisions will be published on this page. Continued use of the site after a revision constitutes acceptance of the revised terms.

Questions about these terms: contact@drugevidence.com.